TrialFrontiers in immunology2022

Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients.

Christophe Masset et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.